These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 367236)

  • 1. Heparin utilization during arterial revascularization.
    Collins GJ; Kimball DB; Rich NM; Andersen CA; McDonald PT
    Am Surg; 1978 Dec; 44(12):753-7. PubMed ID: 367236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
    Patel AA; White CM; Coleman CI
    Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice.
    Bernat A; Hoffmann P; Herbert JM
    Thromb Haemost; 1996 Nov; 76(5):715-9. PubMed ID: 8950779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
    Fiser WP; Fewell JE; Hill DE; Barnes RW; Read RC
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
    Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
    Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative heparin anticoagulation and its reversal.
    Wakefield TW; Stanley JC
    Semin Vasc Surg; 1996 Dec; 9(4):296-302. PubMed ID: 8958606
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impact of protamine sulfate on hemostasis system after operations with artificial circulation].
    Charnaia MA; Klypa TV; Morozov IuA; Shmerko NP; Gladysheva VG; Andriianova AA
    Khirurgiia (Mosk); 2007; (8):17-20. PubMed ID: 17828120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of heparin therapy.
    Gervin AS
    Surg Gynecol Obstet; 1975 May; 140(5):789-96. PubMed ID: 1170648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of enoxaparine-induced bleeding by protamine sulfate.
    Van Ryn-McKenna J; Cai L; Ofosu FA; Hirsh J; Buchanan MR
    Thromb Haemost; 1990 Apr; 63(2):271-4. PubMed ID: 2163553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protamine pretreatment attenuation of hemodynamic and hematologic effects of heparin-protamine interaction. A prospective randomized study in human beings undergoing aortic reconstructive surgery.
    Wakefield TW; Hantler CB; Lindblad B; Whitehouse WM; Stanley JC
    J Vasc Surg; 1986 Jun; 3(6):885-9. PubMed ID: 3712636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant monitoring and neutralization during open heart surgery--a rapid method for measuring heparin and calculating safe reduced protamine doses.
    Umlas J; Taff RH; Gauvin G; Swierk P
    Anesth Analg; 1983 Dec; 62(12):1095-9. PubMed ID: 6650893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of low-dose heparin is safe in carotid endarterectomy and avoids the use of protamine sulfate.
    Paty PS; Darling RC; Kreienberg PB; Chang BB; Groudine SB; Sakawi Y; Worth G; Lloyd WE; Rockmore J; Shah DM
    Cardiovasc Surg; 1999 Jan; 7(1):39-43. PubMed ID: 10073758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-l-lysine: A comparative 'in vitro' study versus protamine sulfate.
    Muralidharan-Chari V; Kim J; Mousa SA
    Thromb Res; 2017 Jul; 155():128-130. PubMed ID: 28538195
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of protamine hollow-fiber device for extracorporeal heparin removal.
    Liang JF; Emregul E; Yang VC
    Blood Purif; 2004; 22(2):198-202. PubMed ID: 15044818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of two schemes of administering the Russian protamine sulfate after extracorporeal circulation in cardiosurgical patients].
    Charnaia MA; Morozov IuA; Gladysheva VG; Isaeva AM
    Anesteziol Reanimatol; 2006; (5):31-3. PubMed ID: 17184058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.